OvPlex Receives UK Ethics Approval For Ovarian Cancer Diagnostic Trial
Initial results suggest that the diagnostic accuracy of this new test will be greater than 97% for early stage ovarian cancer. The advice has come from the company’s
The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) to treat adults with primary membranous nephropathy (pMN).
The patented nanoparticle technology solubilises pharmaceutical compounds in fatty acids and/or fatty alcohols. The formulation achieves aqueous form after dilution with equimolar of protonating agent, thereby keeping the